Cocoa Chou, CPA

Chief Financial Officer

Professional Overview
Cocoa Chou is an accomplished finance executive with over 13 years of experience in the pharmaceutical industry. As the Chief Financial Officer at Kite Pharma, she oversees all financial operations, strategic planning, and risk management initiatives for the fast-growing biopharmaceutical company.

Experience Summary

Current Role
As Chief Financial Officer at Kite Pharma, Cocoa is responsible for leading the company's financial strategy, budgeting, and reporting processes. She has played a crucial role in securing $150 million in Series C funding, which enabled Kite Pharma to advance its innovative pipeline of cell-based cancer immunotherapies. Under her financial stewardship, the company has maintained a strong balance sheet and experienced consistent year-over-year revenue growth of 25%.

Career Progression
Prior to her current role, Cocoa served as the Accounting Manager and Senior Accountant at Kite Pharma, demonstrating a proven track record of advancing within the organization. In these previous positions, she spearheaded the implementation of a new enterprise resource planning (ERP) system, which streamlined financial operations and improved data-driven decision-making.

Academic Background
Cocoa holds a Bachelor of Science in Accounting from the University of California, Los Angeles. She is a Certified Public Accountant (CPA) and has completed executive training programs in Strategic Finance and Corporate Governance at the Stanford Graduate School of Business.

Areas of Expertise

• Financial planning and analysis

• Regulatory compliance and reporting

• Risk management and internal controls

• Mergers, acquisitions, and integration

• Investor relations and capital raising

Professional Impact
Cocoa's strategic financial leadership has been instrumental in Kite Pharma's rapid growth and success. She has played a pivotal role in securing critical funding, optimizing operational efficiency, and ensuring the company's long-term financial stability. Cocoa's expertise in the biopharmaceutical industry and her ability to navigate complex regulatory environments have made her a valuable asset to the Kite Pharma leadership team.

Conclusion
With her exceptional financial acumen, strategic vision, and cross-functional expertise, Cocoa Chou is poised to continue driving Kite Pharma's success and advancing the company's mission to develop transformative cell-based cancer therapies.